BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lai MS, Yan XP, Branch DR, Loriamini M, Chen LM. Ferroptosis in liver diseases: Fundamental mechanism and clinical implications. World J Gastroenterol 2024; 30(32): 3730-3738 [PMID: 39221065 DOI: 10.3748/wjg.v30.i32.3730]
URL: https://www.wjgnet.com/1007-9327/full/v30/i32/3730.htm
Number Citing Articles
1
Amr Ali Mohamed Abdelgawwad El-Sehrawy, Teeba Ammar Rashid, Muhammad Ikram Ullah, Subasini Uthirapathy, Subbulakshmi Ganesan, Abhayveer Singh, Anita Devi, Kamal Kant Joshi, Ahmed Salman Jasim, Abed J. Kadhim. Cutting edge: ferroptosis in metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis and therapyFunctional & Integrative Genomics 2025; 25(1) doi: 10.1007/s10142-025-01579-0
2
Enxiang Zhang. Role of ferroptosis in liver diseases and its implications for therapeutic strategiesFood and Chemical Toxicology 2026; 213: 116102 doi: 10.1016/j.fct.2026.116102
3
Negar Hemmati, Mahdieh Anoush, Bahman Abedi Kiasari, Alireza Torkamani. Targeting ferroptosis as a therapeutic strategy for hepatotoxicityToxicology Reports 2025; 15: 102137 doi: 10.1016/j.toxrep.2025.102137
4
Ting Wang, JiaWei Zeng, JingHao Zhang, XiaoXu Sun, Chao Jiang. Ferroptosis in Neurovascular Unit of Ischemic Stroke: Multidimensional Regulatory Mechanisms and Targeted InterventionsFrontiers in Bioscience-Landmark 2025; 30(11) doi: 10.31083/FBL40737
5
Debabrata Dash, Raj Kumar Koiri, Jian Wu. Hepcidin–Ferroportin Axis, Gut Microbiota, and Ferroptosis Across Chronic Liver Diseases: Mechanistic Integration of an Iron Dysregulation TriadAdvanced Gut & Microbiome Research 2026; 2026(1) doi: 10.1155/agm3/3202391